The excitement over the FDA approval of brexanolone (to be marketed as Zulresso) is a good place to start this week’s roundup. Brexanolone is a derivative of the neurosteroid allopregnanolone, and, while Zulpresso was approved specifically for the treatment of postpartum depression, there is considerable research to indicate that the modulation of neurosteroid systems may… Read More »
This week there are a series of articles related to the recommendations issued by the US Preventive Services Task Force (USPSTF) several weeks ago, stating that all pregnant and postpartum women should be evaluated in order to determine risk for depressive illness and recommends that women at increased risk for perinatal depression should be referred… Read More »
Generic drugmaker Mylan on Tuesday reported lower-than-expected fourth-quarter profit and forecast 2019 earnings well below Wall Street estimates, as it grapples with significant problems at its Morgantown, West Virginia, plant. Mylan said the lower forecast was due to higher projected sales, marketing and research and development costs, and its shares fell about 10 percent. Mylan… Read More »
Over the last few years, there has been an increasing number of articles focusing on perinatal anxiety. Recent studies indicate that anxiety during pregnancy and the postpartum period is common and may occur independently of perinatal depression, although anxiety and depressive symptoms frequently appear together during the perinatal period. This week we have several large… Read More »
Suraj Kund Mela 2019 will be held in Suraj Kund, Haryana, From February 1-17 | (Photo Credits: Twitter & Sarvodaya Hospitals) Chandigarh, January 31: The 33rd Surajkund International Crafts Mela 2019 will begin from February 1, 2019, and will last till February 17. The preparations for the festival are in full swing, and Surajkund is… Read More »